These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 14599865)

  • 1. P63 and EGFR as prognostic predictors in stage IIB radiation-treated cervical squamous cell carcinoma.
    Cho NH; Kim YB; Park TK; Kim GE; Park K; Song KJ
    Gynecol Oncol; 2003 Nov; 91(2):346-53. PubMed ID: 14599865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of cyclooxygenase-2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy.
    Kim YB; Kim GE; Cho NH; Pyo HR; Shim SJ; Chang SK; Park HC; Suh CO; Park TK; Kim BS
    Cancer; 2002 Aug; 95(3):531-9. PubMed ID: 12209745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy.
    Gaffney DK; Haslam D; Tsodikov A; Hammond E; Seaman J; Holden J; Lee RJ; Zempolich K; Dodson M
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):922-8. PubMed ID: 12829126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of p53 and Bcl-2 expression as prognostic markers in invasive cervical carcinoma stage IIb/III patients treated by radiotherapy.
    Jain D; Srinivasan R; Patel FD; Kumari Gupta S
    Gynecol Oncol; 2003 Jan; 88(1):22-8. PubMed ID: 12504622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of human papillomavirus (HPV) status and expression of selected markers (HER2/neu, EGFR, VEGF, CD34, p63, p53 and Ki67/MIB-1) on outcome after (chemo-) radiotherapy in patients with squamous cell carcinoma of uterine cervix.
    Vosmik M; Laco J; Sirak I; Beranek M; Hovorkova E; Vosmikova H; Drastikova M; Hodek M; Zoul Z; Odrazka K; Petera J
    Pathol Oncol Res; 2014 Jan; 20(1):131-7. PubMed ID: 23913252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synchronous coexpression of epidermal growth factor receptor and cyclooxygenase-2 in carcinomas of the uterine cervix: a potential predictor of poor survival.
    Kim GE; Kim YB; Cho NH; Chung HC; Pyo HR; Lee JD; Park TK; Koom WS; Chun M; Suh CO
    Clin Cancer Res; 2004 Feb; 10(4):1366-74. PubMed ID: 14977838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re: "P63 and EGFR as prognostic predictors in stage IIB radiation-treated cervical squamous cell carcinoma".
    Van de Putte G; Vach W
    Gynecol Oncol; 2005 Aug; 98(2):335-6. PubMed ID: 16039312
    [No Abstract]   [Full Text] [Related]  

  • 8. Tumor hypoxia, p53, and prognosis in cervical cancers.
    Haensgen G; Krause U; Becker A; Stadler P; Lautenschlaeger C; Wohlrab W; Rath FW; Molls M; Dunst J
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):865-72. PubMed ID: 11429213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathology significance of p53 and p63 expression in Indonesian cervical squamous cell carcinomas.
    Romus I; Triningsih FE; Mangunsudirdjo S; Harijadi A
    Asian Pac J Cancer Prev; 2013; 14(12):7737-41. PubMed ID: 24460361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the p53 homologue p63 in early cervical neoplasia.
    Quade BJ; Yang A; Wang Y; Sun D; Park J; Sheets EE; Cviko A; Federschneider JM; Peters R; McKeon FD; Crum CP
    Gynecol Oncol; 2001 Jan; 80(1):24-9. PubMed ID: 11136565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of epidermal growth factor receptor signaling decreases p63 expression in head and neck squamous carcinoma cells.
    Matheny KE; Barbieri CE; Sniezek JC; Arteaga CL; Pietenpol JA
    Laryngoscope; 2003 Jun; 113(6):936-9. PubMed ID: 12782800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexpression of cyclooxygenase-2 and thymidine phosphorylase as a prognostic indicator in patients with FIGO stage IIB squamous cell carcinoma of uterine cervix treated with radiotherapy and concurrent chemotherapy.
    Pyo H; Kim YB; Cho NH; Suh CO; Park TK; Yun YS; Kim GE
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):725-32. PubMed ID: 15936552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent chemoradiotherapy with paclitaxel and nedaplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: preliminary results of a phase II study.
    Zhang MQ; Liu SP; Wang XE
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):821-7. PubMed ID: 20207507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of Bax, Bcl-2, and p53 expressions in cervical squamous cell carcinoma treated by radiotherapy.
    Wootipoom V; Lekhyananda N; Phungrassami T; Boonyaphiphat P; Thongsuksai P
    Gynecol Oncol; 2004 Sep; 94(3):636-42. PubMed ID: 15350352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of prognostic factors and therapeutic patterns of recurrent stage Ⅰb-Ⅱa cervical squamous carcinoma treated with radical hysterectomy].
    Ou ZJ; Zhao D; An JS; Sun CY; Huang MN; Li B; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2019 Jun; 54(6):399-405. PubMed ID: 31262124
    [No Abstract]   [Full Text] [Related]  

  • 16. Differential clinical characteristics, treatment response and prognosis of locally advanced adenocarcinoma/adenosquamous carcinoma and squamous cell carcinoma of cervix treated with definitive radiotherapy.
    Chen JL; Huang CY; Huang YS; Chen RJ; Wang CW; Chen YH; Cheng JC; Cheng AL; Kuo SH
    Acta Obstet Gynecol Scand; 2014 Jul; 93(7):661-8. PubMed ID: 24666257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy].
    Ma R; Zhang H; Zou L; Qu Y
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):125-30. PubMed ID: 25877610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation and transcription analyses of the p63 gene in cervical carcinoma.
    Nishi H; Isaka K; Sagawa Y; Usuda S; Fujito A; Ito H; Senoo M; Kato H; Takayama M
    Int J Oncol; 1999 Dec; 15(6):1149-53. PubMed ID: 10568821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of p63 expression in lung cancer by use of complementary DNA and tissue microarray].
    Yu YW; Garber ME; Schlüns K; Pacyna-Gengelbach M; Petersen I
    Zhonghua Bing Li Xue Za Zhi; 2004 Aug; 33(4):324-7. PubMed ID: 15363316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of p63 is associated with radiation resistance and prognosis in oral squamous cell carcinoma.
    Moergel M; Abt E; Stockinger M; Kunkel M
    Oral Oncol; 2010 Sep; 46(9):667-71. PubMed ID: 20656547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.